pramipexole
The       aim of this study was to estimate the costs and cost effectiveness (cost utility)       of pramipexole compared with baseline treatment in patients with early and       advanced PD.
The       aim of this study was to estimate the costs and cost effectiveness (cost utility)       of  @SUBJECT$   @PREDICAT$  with baseline  @OBJECT$  in patients with early and       advanced PD.